Patents by Inventor Alastair Morgan Mackay

Alastair Morgan Mackay has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cardiac Muscle Regeneration Using Mesenchymal Stem Cells
    Publication number: 20090214493
    Abstract: Disclosed is a method for producing cardiomyocytes in vivo by administering to the heart of an individual a cardiomyocyte producing amount of mesenchymal stem cells. These cells can be administered as a liquid injectable or as a preparation of cells in a matrix which is or becomes solid or semi-solid. The cells can be genetically modified to enhance myocardial differentiation and integration. Also disclosed is a method for replacing cells ex vivo in a heart valve for implantation.
    Type: Application
    Filed: March 2, 2009
    Publication date: August 27, 2009
    Applicant: Osiris Therapeutics, Inc.
    Inventors: Mark F. Pittenger, Stephen L. Gordon, Alastair Morgan Mackay, Bradley J. Martin
  • Cardiac muscle regeneration using mesenchymal stem cells
    Patent number: 7514074
    Abstract: Disclosed is a method for producing cardiomyocytes in vivo by administering to the heart of an individual a cardiomyocyte producing amount of mesenchymal stem cells. These cells can be administered as a liquid injectible or as a preparation of cells in a matrix which is or becomes solid or semi-solid. The cells can be genetically modified to enhance myocardial differentiation and integration. Also disclosed is a method for replacing cells ex vivo in a heart valve for implantation.
    Type: Grant
    Filed: October 21, 2003
    Date of Patent: April 7, 2009
    Assignee: Osiris Therapeutics, Inc.
    Inventors: Mark F. Pittenger, Stephen L. Gordon, Alastair Morgan Mackay, Bradley J. Martin
  • Cardiac muscle regeneration using mesenchymal stem cells
    Publication number: 20030103951
    Abstract: Disclosed is a method for producing cardiomyocytes in vivo by administering to the heart of an individual a cardiomyocyte producing amount of mesenchymal stem cells. These cells can be administered as a liquid injectible or as a preparation of cells in a matrix which is or becomes solid or semi-solid. The cells can be genetically modified to enhance myocardial differentiation and integration. Also disclosed is a method for replacing cells ex vivo in a heart valve for implantation.
    Type: Application
    Filed: October 22, 2002
    Publication date: June 5, 2003
    Applicant: Osiris Therapeutics, Inc.
    Inventors: Mark F. Pittenger, Stephen L. Gordon, Alastair Morgan Mackay, Bradley J. Martin
  • Cardiac muscle regeneration using mesenchymal stem cells
    Patent number: 6387369
    Abstract: Disclosed is a method for producing cardiomyocytes in vivo by administering to the heart of an individual a cardiomyocyte producing amount of mesenchymal stem cells. These cells can be administered as a liquid injectible or as a preparation of cells in a matrix which is or becomes solid or semi-solid. The cells can be genetically modified to enhance myocardial differentiation and integration. Also disclosed is a method for replacing cells ex vivo in a heart valve for implantation.
    Type: Grant
    Filed: March 27, 2000
    Date of Patent: May 14, 2002
    Assignee: Osiris Therapeutics, Inc.
    Inventors: Mark F. Pittenger, Stephen L. Gordon, Alastair Morgan Mackay